Loading clinical trials...
Loading clinical trials...
In image-guided radiotherapy (IGRT), the repeated and increasingly intensive use of on-board positioning imaging, using 2D or 3D Mega-Volt (MV) or kilo-Volt (kV) imaging devices (cone-beam or CBCT scanners), is leading the international medical community to question the potential impact of these additional doses delivered to the patient, especially in at-risk populations such as children and young adults. The doses delivered to the patient by positioning imaging are still relatively unknown, due to the lack of experimental means and software available in clinical routine to easily and accurately evaluate these doses. The main objective is to estimate by personalized Monte Carlo calculation the physical doses delivered to the patient's organs by the onboard imaging systems during their radiotherapy treatment. The obtained imaging doses will be compared according to different irradiation scenarios commonly used in clinical routine as well as according to the treated location.
The study will consist of 2 successive steps: * Step 1 : for a set of patients selected in the clinical centers participating in the study, 3D maps of physical doses delivered to organs by positioning imaging will be calculated based on the patient's CT image used by the treatment planning system (dosimetric calculation performed by Monte Carlo method). * Step 2/ all the new dosimetric data, average organ doses and dose volume histogram, will be the subject of a more global analysis, which will be returned to the project's clinical partner centers.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Institut de Radiothérapie et Radiochirurgie H. Hartmann
Levallois-Perret, Hauts-de-Seine, France
Hôpital Henri Mondor - AP-HP
Créteil, Val-de-Marne, France
Institut Gustave Roussy
Villejuif, Val-de-Marne, France
Groupe AMETHYST
Colombes, France
Institut Curie
Paris, France
Hôpital Saint-Louis - AP-HP
Paris, France
Hôpital La Pitié Salpêtrière - AP-HP
Paris, France
Hôpital européen Georges-Pompidou AP-HP
Paris, France
Hôpital Tenon - AP-HP
Paris, France
Start Date
May 15, 2023
Primary Completion Date
May 14, 2025
Completion Date
May 14, 2025
Last Updated
April 18, 2023
320
ESTIMATED participants
3D maps of physical doses
OTHER
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
NCT05372640
NCT05673200
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions